Vsee Health (VSEEW) Net Income towards Common Stockholders (2022 - 2026)

Vsee Health has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 34.33% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$13.3 million (up 78.23% YoY), and the FY2025 full-year result was -$14.7 million, up 74.6% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$2.6 million, up from -$7.8 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $94750.0 in Q1 2024, with the low at -$53.9 million in Q3 2024.
• Historically, Net Income towards Common Stockholders has averaged -$5.1 million across 5 years, with a median of -$1.0 million in 2022.
• The largest YoY upside for Net Income towards Common Stockholders was 113.2% in 2024 against a maximum downside of 30314.72% in 2024.
• Vsee Health's Net Income towards Common Stockholders stood at -$1.2 million in 2022, then sank by 102.94% to -$2.5 million in 2023, then retreated by 28.01% to -$3.2 million in 2024, then tumbled by 142.99% to -$7.8 million in 2025, then soared by 66.64% to -$2.6 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.6 million (Q1 2026), -$7.8 million (Q4 2025), and -$289745.0 (Q3 2025), per Business Quant data.